Copart, Inc logo

Copart, IncNasdaq: CPRT

Industrials · Diversified Support Services

$29.58

-3.77%

Vol: 8.8M

Research Digest

Thursday, June 18, 2026

Neutral

No significant overnight updates

No material news in the last 48 hours.

Price 50d 200d

Previous Market Intelligence

13 days
Jun 17No significant overnight updatesNeutral

No material news in the last 48 hours.

Jun 16No significant overnight updatesNeutral

No material news in the last 48 hours.

Jun 15No significant overnight updatesNeutral

No material news in the last 48 hours.

Jun 14No significant overnight updatesNeutral

No material news in the last 48 hours.

May 21Copart reports Q3 fiscal 2026 earnings May 21; analysts expect $0.41 EPS on $1.20B revenueNegative

Copart will release Q3 fiscal 2026 earnings after market close on Thursday, May 21, 2026, with a conference call at 5:30 PM ET. Wall Street consensus expects EPS of $0.41 on revenue of $1.20B, with the market projecting revenue decline of 2.1% YoY. Short interest is rising ahead of the report. The company missed Q2 estimates with $1.12B revenue (-3.6% YoY). JPMorgan and Barclays trimmed price targets to $34 and $32 citing fee pressure from insurance partners. Stock at $32.30 as of May 15.

May 20Copart heads into Q3 fiscal 2026 earnings on May 21 with short interest up 8% and price targets cut to $32-$34 amid fee-rate competitive pressure.Negative

Copart will report Q3 fiscal 2026 results after market close on May 21, with Wall Street expecting EPS of $0.41 on revenue of $1.20B, a 2.4% YoY EPS decline. Short interest rose 7.99% to ~32.79M shares (3.76% of float) as of April 30 ahead of the print. Analysts have trimmed targets, with JPMorgan to $34 and Barclays to $32, citing competitive pressure on fee rates following a Q2 miss where revenue fell 3.6% YoY to $1.12B and EPS dropped to $0.36 from $0.40. The setup creates elevated risk into the print given recent execution concerns. Average price target now sits at $42.67 with the stock around $32-$33.

May 19Copart short interest rose ~8% ahead of May 21 fiscal Q3 2026 earnings as analysts trim price targets on competitive fee pressure.Negative

As of disclosures around May 18, 2026, Copart's short interest climbed ~7.99% to roughly 32.8M shares (~3.76% of float) heading into its fiscal Q3 2026 earnings release on May 21, 2026. The setup is cautious: JPMorgan and Barclays trimmed targets to $34 and $32 citing spreading competitive pressure on fee rates after Q2 2026 missed (EPS $0.36 vs $0.40 prior, revenue down 3.6% YoY). This matters because earnings are the next binary catalyst, with consensus revenue around $1.20B. Bear case: continued fee compression from IAA/competitive auction platforms could pressure margins; shares are down ~45% YoY.

May 18Copart heads into May 21 Q3 FY2026 earnings with stock down 45% YoY at $32.30Mixed

Copart will report fiscal Q3 2026 results after the close on Thursday, May 21, followed by a 5:30 p.m. ET conference call. Shares traded around $32.30 as of May 15 with a market cap near $31.4B, reflecting a 45.5% decline over the past year amid ongoing insurance-volume headwinds. Street price targets range roughly $33-$52 as analysts weigh share-loss risk with insurance carriers. The UK unit also disclosed sustainability work with supply-chain partners to reduce Scope 3 emissions. The earnings print and any commentary on insurance-customer share will be the key near-term catalyst.

May 15Copart confirms Q3 FY2026 earnings release on May 21 as JPMorgan and Barclays cut price targets ahead of reportNegative

Copart announced it will release Q3 fiscal 2026 results after market close on Thursday, May 21, 2026, followed by a conference call. JPMorgan cut its price target to $34 from $45 and kept a Neutral rating, while Barclays lowered its target to $32 from $33 with an Underweight rating. Shares trade around $39.15, down 14% over the last 90 days and roughly 45.6% over the past year. Average analyst rating is Hold, with a consensus 12-month target near $44.4 implying ~31% upside. Investors will watch for commentary on insurance volumes and international segment growth on May 21.

May 14Copart sets Q3 fiscal 2026 earnings release for May 21 amid 45% one-year stock decline and analyst price target cuts.Negative

Copart announced it will release Q3 fiscal 2026 results after market close on May 21, 2026, with consensus EPS estimate of $0.41. The stock has declined approximately 16% over the past 3 months and 45.66% over the past year, currently trading near $33.94. Analyst sentiment is cautious: JPMorgan lowered its price target to $34 from $45 (Neutral), and Barclays cut to $32 from $33 (Underweight). The prior quarter (Feb 19) saw an EPS miss at $0.36 versus $0.39 consensus. CEO Jeffrey Liaw sold 26,213 shares on April 15 at $33.18. Average analyst rating is Hold with a 12-month target of $44.40.

May 13Copart heads into its May 21 earnings report under analyst pressure after Barclays initiated Underweight and Weiss Ratings downgraded the stock to Sell.Negative

Copart is scheduled to report fiscal Q3 2026 results on May 21, 2026, with consensus EPS of $0.41. The stock has been under sustained pressure, down ~16% over the past three months and ~45% over the past year. Analyst sentiment has soured: Barclays initiated coverage at Underweight with a $32 price target, JPMorgan trimmed its target to $34 (from $45) keeping a Neutral rating, and Weiss Ratings downgraded CPRT from Hold to Sell on May 1. Provident Investment Management cut its CPRT stake by 41.6% in its most recent 13F. Despite the bearish tone, the consensus average price target of $44.40 still implies ~30% upside from current levels, with consensus rating Hold across 5 analysts.

May 12Copart faces weak demand as JPMorgan and Barclays cut targets to $34/$32 and Weiss downgrades to sell ahead of May 21 earningsNegative

Copart faces a bearish narrative ahead of its May 21 fiscal Q3 2026 earnings (EPS estimate $0.41), with shares down 45% over the past year to $33.29. JPMorgan lowered its price target to $34 from $45 (Neutral), and Barclays cut to $32 from $33 (Underweight) on competitive pressure and weak demand for used vehicles. Weiss Ratings downgraded from Hold (C-) to Sell (D+) on May 1. CEO Jeffrey Liaw sold 26,213 shares on April 15 at $33.18 totaling ~$870K. Provident Investment Management cut its position 41.6% in Q4. Consensus rating Hold with $44.40 average target implying ~31% upside.

May 11Copart faces analyst downgrades as Barclays and JPMorgan cut price targets ahead of fiscal Q3 earnings on May 21, 2026.Negative

Barclays trimmed its Copart price target to $32 from $33 and kept an Underweight rating, citing fiscal Q2 results that missed expectations. Both JPMorgan and Barclays reduced price targets into the low $30s, signaling caution about competitive pressures and recent earnings weakness. Copart shares are down 45% over the past year and 16.15% over the past three months as of May 3, 2026. The company will report fiscal Q3 2026 earnings on May 21, 2026, with analysts expecting EPS of $0.41-$0.42, flat year-over-year. Concerns center on auction volumes and competitive pressures. Vanguard disclosed a 6.86% beneficial ownership stake (66.09M shares) via a Schedule 13G filing.

Sector Peers

CompanyPriceDay1MFwd P/EBetaMkt Cap
CTASCINTAS$169.41-4.13%-1.5%31.3x0.93$67.9B
CPRTCOPART$29.58-3.77%-10.9%17.5x1.00$27.3B
LDOSLEIDOS$108.85-4.17%-13.7%8.3x0.52$13.7B
CATCATERPILLAR$956.01+1.12%+11.1%31.8x1.60$440.3B
GEGENERAL$357.36+1.60%+25.1%41.1x1.38$373.0B
GEVGE$1,051.15+7.00%+3.7%42.8x1.04$281.8B

Key Fundamentals

Market Cap$27.3B
P/E (TTM)18.3
Forward P/E17.5
Beta1.00
Div Yield
Prev Close$30.74

RSI (14-Day)

32Neutral
0305070100

52-Week Range

$29.50$29.58$50.11
From High-41.0%
From Low+0.3%

Moving Averages

50d SMA
$33.10-10.6%
200d SMA
$39.95-26.0%

Price below 200d MA — bearish structure.

Historical Returns

1W
-10.7%
1M
-12.3%
3M
-21.4%
6M
-28.4%
1Y
-53.4%
YTD
-21.7%

Volume

Today8.8M
20d Avg8.4M
Ratio1.05x